Literature DB >> 10508180

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.

C Burkhart1, G Y Liu, S M Anderton, B Metzler, D C Wraith.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a CD4(+) T cell-mediated, inflammatory disease with similarities to multiple sclerosis in humans. Intranasal (i.n.) administration of a myelin basic protein (MBP)-derived peptide can protect susceptible mice from EAE. The mechanisms underlying this phenomenon, however, remain unclear. To analyze the phenotypic and functional changes taking place during the induction of tolerance by peptide inhalation, we have studied the fate of CD4(+) T cells after i.n. peptide application using transgenic mice expressing a TCR specific for the N-terminal peptide (Ac1-9) of MBP. Peripheral T cell death was variably observed in TCR transgenic mice after a single i.n. administration of antigenic peptide but was transient and incomplete. Transgenic spleen cells and cervical lymph node cells responded with a cytokine burst to peptide inhalation and hyperproliferation when re-stimulated in vitro. Transfer experiments demonstrated that the duration of peptide administration required to induce tolerance depended on the precursor frequency of T cells in recipient animals. The stringency of i.n. peptide treatment was increased so as to test the efficacy of tolerance induction both in vitro and in vivo in the presence of high precursor frequencies of antigen-specific T cells. Multiple i.n. doses of peptide completely protected TCR transgenic mice from EAE induced with myelin. Such repeated peptide administration resulted in down-regulation of the capacity of antigen-specific CD4(+) T cells to proliferate or to produce IL-2, IFN-gamma and IL-4 but increased the production of IL-10. The role of IL-10 in suppression of EAE in vivo was demonstrated by neutralization of IL-10. This completely restored susceptibility to EAE in mice previously protected by i.n. peptide. Considering the immunosuppressive properties of IL-10, T cells which are resistant to apoptosis might act as regulatory cells and mediate bystander suppression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508180     DOI: 10.1093/intimm/11.10.1625

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  75 in total

Review 1.  Control of immune pathology by IL-10-secreting regulatory T cells.

Authors:  S Fowler; F Powrie
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.

Authors:  G F Hoyne; M J Dallman; J R Lamb
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

3.  Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy.

Authors:  A D Dick; V Sharma; J Liversidge
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 4.  Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.

Authors:  S M Anderton
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

Review 5.  Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

Authors:  M Peakman; C M Dayan
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

Review 6.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

7.  IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice.

Authors:  A-R Youssef; C-R Shen; C-L Lin; R N Barker; C J Elson
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

8.  Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge.

Authors:  Neil Taylor; Karen McConachie; Karen McConnachie; Claudia Calder; Rosemary Dawson; Andrew Dick; Jonathon D Sedgwick; Janet Liversidge
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

9.  Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function.

Authors:  Kirsty S Nicolson; Emma J O'Neill; Anette Sundstedt; Heather B Streeter; Sophie Minaee; David C Wraith
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

10.  Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.

Authors:  Gouri Chattopadhyay; Ethan M Shevach
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.